The estimated Net Worth of Edward Stelmakh is at least $155 Тысяча dollars as of 3 October 2023. Mr Stelmakh owns over 16,662 units of OptimizeRx Corp stock worth over $155,384 and over the last 2001 years he sold OPRX stock worth over $0.
Mr has made over 4 trades of the OptimizeRx Corp stock since 2022, according to the Form 4 filled with the SEC. Most recently he exercised 16,662 units of OPRX stock worth $121,299 on 3 October 2023.
The largest trade he's ever made was exercising 16,662 units of OptimizeRx Corp stock on 3 October 2023 worth over $121,299. On average, Mr trades about 5,282 units every 52 days since 23. As of 3 October 2023 he still owns at least 21,344 units of OptimizeRx Corp stock.
You can see the complete history of Mr Stelmakh stock trades at the bottom of the page.
Edward Stelmakh C.M.A., M.B.A., MBA is the CFO & COO at OptimizeRx Corp.
Edward's mailing address filed with the SEC is C/O OPTIMIZERX CORPORATION, 260 CHARLES STREET, SUITE 302, WALTHAM, MA, 02453.
Over the last 2001 years, insiders at OptimizeRx Corp have traded over $20,012,815 worth of OptimizeRx Corp stock and bought 258,753 units worth $1,128,145 . The most active insiders traders include Investment Company, Inc. Awm, Bradley Louis Radoff и David Harrell. On average, OptimizeRx Corp executives and independent directors trade stock every 32 days with the average trade being worth of $183,485. The most recent stock trade was executed by Patrick D Spangler on 5 June 2024, trading 10,061 units of OPRX stock currently worth $73,244.
optimizerx partners with pharmaceutical companies to offer electronic versions of their patient savings and support materials within the eprescribing workflow of leading electronic health record platforms. using the samplemd technology, providers can more efficiently distribute savings and support materials to their patients. the ecoupon technology, available in the eprescribing workflow of over 300,000+ providers, has expanded the distribution of savings and support materials to millions of patients throughout the us and aims to increase adherence rates and affordability of prescribed medications. about optimizerx corp. optimizerx corp. provides unique consumer and physician platforms to help patients better afford and comply with their medications, while offering pharmaceutical companies effective ways to expand awareness, affordability and adherence to their brands. for more information on samplemd, please call us at (877) 568-3840 or visit www.samplemd.com.
OptimizeRx Corp executives and other stock owners filed with the SEC include: